147 related articles for article (PubMed ID: 38680241)
1. "Minimally Invasive" Skin Grafting With Enzymatic Debridement and Autologous Skin Cell Spray: A Retrospective Case Series.
Kahn SA; Raghava N; Gaweda G; Hink A; Holmes Iv J; Hickerson W; Carter JE
Ann Burns Fire Disasters; 2023 Dec; 36(4):355-360. PubMed ID: 38680241
[TBL] [Abstract][Full Text] [Related]
2. Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers.
Carter JE; Carson JS; Hickerson WL; Rae L; Saquib SF; Wibbenmeyer LA; Becker RV; Walsh TP; Sparks JA
Adv Ther; 2022 Nov; 39(11):5191-5202. PubMed ID: 36103088
[TBL] [Abstract][Full Text] [Related]
3. Maximizing wound coverage in full-thickness skin defects: A randomized-controlled trial of autologous skin cell suspension and widely meshed autograft versus standard autografting.
Henry S; Mapula S; Grevious M; Foster KN; Phelan H; Shupp J; Chan R; Harrington D; Mashruwala N; Brown DA; Mir H; Singer G; Cordova A; Rae L; Chin T; Castanon L; Bell D; Hughes W; Molnar JA
J Trauma Acute Care Surg; 2024 Jan; 96(1):85-93. PubMed ID: 38098145
[TBL] [Abstract][Full Text] [Related]
4. Outcomes for Hand Burns Treated With Autologous Skin Cell Suspension in 20% TBSA and Smaller Injuries.
Taylor GM; Barnett SA; Tuggle CT; Carter JE; Phelan HA
J Burn Care Res; 2021 Nov; 42(6):1093-1096. PubMed ID: 34143200
[TBL] [Abstract][Full Text] [Related]
5. Analysis of real-world length of stay data and costs associated with use of autologous skin cell suspension for the treatment of small burns in U.S. centers.
Carson JS; Carter JE; Hickerson WL; Rae L; Saquib SF; Wibbenmeyer LA; Becker RV; Sparks JA; Walsh TP
Burns; 2023 May; 49(3):607-614. PubMed ID: 36813602
[TBL] [Abstract][Full Text] [Related]
6. Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF).
Waldner M; Ismail T; Lunger A; Klein HJ; Schweizer R; Alan O; Breckwoldt T; Giovanoli P; Plock JA
Scars Burn Heal; 2022; 8():20595131211052394. PubMed ID: 35024172
[TBL] [Abstract][Full Text] [Related]
7. Use of Autologous Skin Cell Suspension for the Treatment of Hand Burns: A Pilot Study.
Barnett SA; Carter JE; Tuggle CT
J Hand Surg Glob Online; 2021 May; 3(3):117-123. PubMed ID: 35415550
[TBL] [Abstract][Full Text] [Related]
8. Autologous Skin Cell Suspension for Full-Thickness Skin Defect Reconstruction: Current Evidence and Health Economic Expectations.
Kahn SA; Carter JE; Wilde S; Chamberlain A; Walsh TP; Sparks JA
Adv Ther; 2024 Mar; 41(3):891-900. PubMed ID: 38253788
[TBL] [Abstract][Full Text] [Related]
9. [Effects of unified surgical scheme for wounds on the treatment outcome of patients with extensive deep burn].
Tang W; Li X; Deng Z; Zhang Z; Zhang X; Zhang T; Zhong X; Chen B; Liu C
Zhonghua Shao Shang Za Zhi; 2015 Aug; 31(4):254-8. PubMed ID: 26715635
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of the Use of Autologous Cell Harvesting Device Compared to Standard of Care for Treatment of Severe Burns in the United States.
Kowal S; Kruger E; Bilir P; Holmes JH; Hickerson W; Foster K; Nystrom S; Sparks J; Iyer N; Bush K; Quick A
Adv Ther; 2019 Jul; 36(7):1715-1729. PubMed ID: 31065995
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries.
Holmes Iv JH; Molnar JA; Carter JE; Hwang J; Cairns BA; King BT; Smith DJ; Cruse CW; Foster KN; Peck MD; Sood R; Feldman MJ; Jordan MH; Mozingo DW; Greenhalgh DG; Palmieri TL; Griswold JA; Dissanaike S; Hickerson WL
J Burn Care Res; 2018 Aug; 39(5):694-702. PubMed ID: 29800234
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of the safety and effectiveness of the RECELL
Holmes JH; Molnar JA; Shupp JW; Hickerson WL; King BT; Foster KN; Cairns BA; Carter JE
Burns; 2019 Jun; 45(4):772-782. PubMed ID: 30578048
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessment of safety and efficacy of intravenous delivery of autologous adipose-derived regenerative cells (ADRCs) in the treatment of severe thermal burns using a porcine model.
Foubert P; Liu M; Anderson S; Rajoria R; Gutierrez D; Zafra D; Tenenhaus M; Fraser JK
Burns; 2018 Sep; 44(6):1531-1542. PubMed ID: 29958745
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic debridement in critically injured burn patients - Our experience in the intensive care setting and during burn resuscitation.
Bowers C; Randawa A; Sloan B; Anwar U; Phipps A; Muthayya P
Burns; 2022 Jun; 48(4):846-859. PubMed ID: 34493422
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Allogeneic Adipose Stem Cells in Polyethylene Glycol-Fibrin Hydrogels as an Adjunct to Meshed Autografts After Sharp Debridement of Deep Partial Thickness Burns.
Burmeister DM; Stone R; Wrice N; Laborde A; Becerra SC; Natesan S; Christy RJ
Stem Cells Transl Med; 2018 Apr; 7(4):360-372. PubMed ID: 29457376
[TBL] [Abstract][Full Text] [Related]
16. Cell-spray auto-grafting technology for deep partial-thickness burns: Problems and solutions during clinical implementation.
Esteban-Vives R; Corcos A; Choi MS; Young MT; Over P; Ziembicki J; Gerlach JC
Burns; 2018 May; 44(3):549-559. PubMed ID: 29183637
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hydrosurgical excision combined with skin grafting in the treatment of deep partial-thickness and full-thickness burns: A two-year retrospective study.
Cao YL; Liu ZC; Chen XL
Burns; 2023 Aug; 49(5):1087-1095. PubMed ID: 35941025
[TBL] [Abstract][Full Text] [Related]
18. [Effects of early debridement and conservative eschar removal followed by wound coverage with acellular dermal matrix in the treatment of children with deep burns].
Liang Y; Shi W; Shao Y; Liu XZ; Gong HM; Cao GH; Gao C; Xin NJ; Song GD
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2024 Apr; 40(4):348-357. PubMed ID: 38664029
[No Abstract] [Full Text] [Related]
19. Comparison of therapeutic effects between artificial dermis combined with autologous split-thickness skin grafting and autologous intermediate-thickness skin grafting alone in severely burned patients: A prospective randomised study.
Shang F; Lu YH; Gao J; Hou Q
Int Wound J; 2021 Feb; 18(1):24-31. PubMed ID: 33124156
[TBL] [Abstract][Full Text] [Related]
20. Intermediate Skin Substitutes Are Unnecessary in Small (<10% TBSA) Burns.
Lacey AM; Maniago E; Gillenwater TJ; Yenikomshian H; Garner WL
J Burn Care Res; 2020 Sep; 41(5):926-928. PubMed ID: 32485731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
